Home › Funds › Rock Springs Capital Management LP › ALNY

Rock Springs Capital Management LP position in ALNY

ALNYLAM PHARMACEUTICALS INC · Health Care

Rock Springs Capital Management LP reported holding 66,750 shares of ALNY (ALNYLAM PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$20.1M, representing 0.98% of its reported portfolio and ranking #33 among its reported holdings. Rock Springs Capital Management LP has disclosed ALNY holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)66.75K sh
Reported value held$20.09M
Portfolio Weight0.98%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Rock Springs Capital Management LP's ALNY position evolved

Rock Springs Capital Management LP first disclosed a stake in ALNY in Q3 2023 at 279,500 shares (US$49.5M). The position peaked in Q3 2024 at 250,000 shares, worth US$68.8M. Across 12 filings, Rock Springs Capital Management LP increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 66,750 shares valued at US$20.1M — a reduction of -7,250 shares quarter over quarter.. Notable position changes include a 86% trim in Q1 2024 (shares rose 63% over the following quarter), a 669% increase in Q2 2024 (shares rose 13% over the following quarter), a 44% trim in Q1 2025 (shares rose 20% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 279.50K $49.50M New
Q4 2023 235.00K $44.98M Reduce
Q1 2024 32.50K $4.86M Reduce
Q2 2024 250.00K $60.75M Add
Q3 2024 250.00K $68.76M Hold
Q4 2024 256.20K $60.29M Add
Q1 2025 143.25K $38.68M Reduce
Q2 2025 100.00K $32.61M Reduce
Q3 2025 74.25K $33.86M Reduce
Q4 2025 71.25K $28.33M Reduce
Q1 2026 74.00K $24.48M Add
Q2 2026 66.75K $20.09M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ALNY and 13F data

ALNY (ALNYLAM PHARMACEUTICALS INC) is a Health Care company. 36 other funds we track also report a position in ALNY — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.70B), Baillie Gifford & Co (US$734.5M), Orbis Allan Gray Ltd (US$598.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ALNY

All ALNY fund holders →

FAQ

How long has Rock Springs Capital Management LP held ALNY?

Rock Springs Capital Management LP has disclosed ALNY holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Rock Springs Capital Management LP's current position in ALNY?

As of Q2 2026, Rock Springs Capital Management LP holds 66.75K shares of ALNY (ALNYLAM PHARMACEUTICALS INC), valued at $20.09M, representing 0.98% of its reported portfolio and ranking #33.

Has Rock Springs Capital Management LP been buying or selling ALNY?

In the latest 13F filing (Q2 2026), Rock Springs Capital Management LP reduced its position in ALNY. The position peaked in Q3 2024 at 250.00K shares.

Which other funds hold ALNY?

Other major institutional holders of ALNY include T. Rowe Price Investment Management, Inc., Baillie Gifford & Co, Orbis Allan Gray Ltd, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.